We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

October 3, 2014

v. Takeda Pharmaceuticals U.S.A., Inc. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


  1. December 15, 2016

    Takeda IP Suit Over Hikma Gout Flare Drug Is Reopened

    A Delaware federal judge has reopened Takeda Pharmaceuticals USA Inc.'s suit accusing West-Ward Pharmaceutical Corp. and parent Hikma Pharmaceuticals PLC of infringing five patents through competing gout flare drug Mitigare, ruling Wednesday that a second amended complaint contains sufficiently detailed allegations.

1 other articles on this case. View all »


To view the parties, register now.